Stakeholders want government to revamp steel plants to check importation
Businessam StaffMay 31, 2019
Stakeholders in the Nigerian metallurgical industry have called for the development of finance strategies to encourage the growth of
Nigeria’s manufacturing index expands further
Businessam StaffMarch 28, 2019
The Manufacturing Purchasing Managers’ Index (PMI) sustained its upswing in March as it increased to 57.4 index points. This current
Manufacturers want harmonisation of taxes, levies for higher productivity
Businessam StaffMarch 27, 2019
Worried about the implications of additional tax burden on local producers, the Manufacturers Association of Nigeria (MAN) has urged
GE jettisoning its biomanufacturing-in-a-box business for $21.4bn
Businessam StaffFebruary 27, 2019
General Electric, which pioneered the factory-in-a-box concept for biomanufacturing, is bailing out of the business. It has agreed to
Roche bulks up in gene therapy and hemophilia with $4.3bn Spark buyout
Chris IkosaFebruary 27, 2019
Late-to-the-game Roche has finally made a move in gene therapy, one of the biopharma industry’s most sought-after and expensive
Manufacturing cuts seen in Sandoz autonomy within Novartis
Businessam StaffFebruary 6, 2019
Sandoz is set to become autonomous within Novartis, the drug manufacturer, but this will come at a cost expected to involve cuts to
LCCI wants FG to address bad roads, rising vehicle costs constraints for real sector
Businessam StaffFebruary 6, 2019
Citing the need to review its backward integration strategy, operators in the real sector have stated that lack of good road
Nestle Nigeria redesigns logo of water product
Businessam StaffJanuary 31, 2019
Table water manufacturer, Nestle Nigeria Plc, has unvieled its redesigned logo for its product, Nestle Pure Life, as it strives
Renault names new leaders as scandal-hit Ghosn bows out
Businessam StaffJanuary 24, 2019
Renault appointed Michelin boss Jean-Dominique Senard as its new chairman on Thursday, after Carlos Ghosn was forced to resign in the
Pfizer, Merck KGaA’s Bavencio takes a hit with second ovarian cancer failure
Businessam StaffJanuary 2, 2019
Back in November, Pfizer and Merck KGaA reported that immuno-oncology drug Bavencio had failed a late-stage ovarian cancer trial. And